CSIMarket
 


Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Income from Cont. Operations Growth by Quarter and Year

Boston Scientific's Income from Cont. Operations results by quarter and year




BSX Income from Cont. Operations (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 209.00 3,996.00 432.00
III Quarter September - -155.00 126.00 555.00
II Quarter June - -147.00 154.00 298.00
I Quarter March 341.00 11.00 386.00 -615.00
FY   341.00 -82.00 4,662.00 670.00



BSX Income from Cont. Operations first quarter 2021 Y/Y Growth Comment
Boston Scientific Corporation showed record Income from Cont. Operations surge in the first quarter with 3000% from the first quarter 2020, to $ 341.00 millions.

According to the results reported in the first quarter, Boston Scientific Corporation achieved the best Income from Cont. Operations growth in Medical Equipment & Supplies industry. While Boston Scientific Corporation' s Income from Cont. Operations doubling of 3000% ranks overall at the positon no. 36 in the first quarter.




BSX Income from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -94.77 % 825 % 52.65 %
III Quarter September - - -77.3 % 280.14 %
II Quarter June - - -48.32 % 2.76 %
I Quarter March 3000 % -97.15 % - -
FY   - - 595.82 % -20.52 %

Financial Statements
Boston Scientific's first quarter 2021 Income from Cont. Operations $ 341.00 millions BSX's Income Statement
Boston Scientific's first quarter 2020 Income from Cont. Operations $ 11.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Income from Cont. Operations Growth >>


BSX Income from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - 3071.43 % -22.16 %
III Quarter September - - -18.18 % 86.24 %
II Quarter June - - -60.1 % -
I Quarter March 63.16 % -99.72 % -10.65 % -
FY (Year on Year)   - - 595.82 % -20.52 %




Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #1
Overall #36

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
3000 % 205.84 % -97.41 %
(Mar 31 2021)   (Mar 31 2020)
Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #1
Overall #36
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
3000 % 205.84 % -97.41 %
(Mar 31 2021)   (Mar 31 2020)

Income from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Boston Scientific's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
3071.43 % 128.44 % -99.72 %
(Dec 31 2019)  


BSX's I. Quarter Q/Q Income from Cont. Operations Comment
Boston Scientific Corporation achieved in the I. Quarter 2021 below company average Income from Cont. Operations jump of 63.16% quarter on quarter, to $ 341.00 millions.

I. Quarter 2021 BSX's Income from Cont. Operations Q/Q growth were a mixed bag, although beneath the ordinary rise of 128.44 %, yet it shows a quite improvement compare to the -99.72% in the I. Quarter 2020.

Within Medical Equipment & Supplies industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Boston Scientific's Income from Cont. Operations growth quarter on quarter, overall rank is 208.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #4
Healthcare Sector #9
Overall #208
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #4
Healthcare Sector #9
Overall #208
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
3071.43 % 128.44 % -99.72 %
(Dec 31 2019)  


BSX's I. Quarter Q/Q Income from Cont. Operations Comment
Boston Scientific Corporation achieved in the I. Quarter 2021 below company average Income from Cont. Operations jump of 63.16% quarter on quarter, to $ 341.00 millions.

Even if the I. Quarter 2021 Boston Scientific's Income from Cont. Operations sequential growth was lower than the average , this has been still good news, as the current surge, outshines the -99.72% Income from Cont. Operations surge in the I. Quarter 2020

Within Medical Equipment & Supplies industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Boston Scientific's Income from Cont. Operations growth quarter on quarter, overall rank is 208.


Boston Scientific's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Income from Cont. Operations 12 Months Ending $ 248.00 $ -82.00 $ 3,705.00 $ 3,986.00 $ 4,287.00
Y / Y Income from Cont. Operations Growth (TTM) -94.22 % - 239.91 % 185.53 % 138.56 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 1069 # 0 # 68 # 76 # 46
Seqeuential Income from Cont. Operations Change (TTM) - - -7.05 % -7.02 % -8.79 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # 1539 # 1275 # 1455




Cumulative Income from Cont. Operations growth Comment
Boston Scientific showed decline, but improvement compare to trailing twelve month Income from Cont. Operations decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Boston Scientific's annual Income from Cont. Operations decrease would be -94.22% year on year to $248 millions.

In the Healthcare sector 78 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 1069.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
365.18 %
32.55 %
-98.46 %
(Jun 30 2018)  

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 0
Healthcare Sector # 79
Overall # 1069

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1506.73 %
260.83 %
-96.53 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Income from Cont. Operations growth Comment
Boston Scientific showed decline, but improvement compare to trailing twelve month Income from Cont. Operations decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Boston Scientific's annual Income from Cont. Operations drop would be -94.22% year on year to $248 millions.

In the Healthcare sector 78 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 1069.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
365.18 %
32.55 %
-98.46 %
(Jun 30 2018)  


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 0
Healthcare Sector # 79
Overall # 1069

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1506.73 %
260.83 %
-96.53 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
BSX's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for BSX's Competitors
Income from Cont. Operations Growth for Boston Scientific's Suppliers
Income from Cont. Operations Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2021
Boston Scientific Corporation3,000.00%$ 3,000.000 millions
Vanda Pharmaceuticals Inc 1,679.84%$ 1,679.835 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

INFU's Profile

Stock Price

INFU's Financials

Business Description

Fundamentals

Charts & Quotes

INFU's News

Suppliers

INFU's Competitors

Customers & Markets

Economic Indicators

INFU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071